Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -3099.93% is 272% below its 5-year average of -832.39%, near the high end of its 5-year range (-33973.08%–3521.87%).
67.89% above its 12-month average of -9653.90%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
-3099.93%
OPERATING MARGIN AVG TTM
-9653.90%
OPERATING MARGIN AVG 3Y
-1540.61%
OPERATING MARGIN AVG 5Y
-832.39%
OPERATING MARGIN AVG 10Y
-584.60%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+67.89%
CURRENT VS 3Y AVG
-101.21%
CURRENT VS 5Y AVG
-272.41%
CURRENT VS 10Y AVG
-430.27%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 836 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cartesian Therapeutics, Inc.
Market Cap
$203.40M
Operating Margin
-3099.93%
TTM Avg
-9653.90%
3Y Avg
-1540.61%
5Y Avg
-832.39%
Market Cap
$208.63M
Operating Margin
16.75%
TTM Avg
16.40%
3Y Avg
14.66%
5Y Avg
13.83%
Market Cap
$202.04M
Operating Margin
-1210.58%
TTM Avg
-725.13%
3Y Avg
-451.25%
5Y Avg
-300.83%
Market Cap
$205.81M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$205.40M
Operating Margin
-692.83%
TTM Avg
-418.51%
3Y Avg
-274.13%
5Y Avg
-339.94%
Market Cap
$208.65M
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$208.47M
Operating Margin
-613.66%
TTM Avg
-295.68%
3Y Avg
-148.45%
5Y Avg
-98.97%
Market Cap
$200.49M
Operating Margin
-18.58%
TTM Avg
-22.82%
3Y Avg
-47.54%
5Y Avg
-46.03%
Market Cap
$211.33M
Operating Margin
40.94%
TTM Avg
-5.20%
3Y Avg
-130.22%
5Y Avg
-446.71%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | $203.40M | -3099.93% | -9653.90% | -1540.61% | -832.39% |
| Pro-Dex, Inc. (PDEX)vs › | $208.63M | 16.75% | 16.40% | 14.66% | 13.83% |
| Surrozen, Inc. (SRZN)vs › | $202.04M | -1210.58% | -725.13% | -451.25% | -300.83% |
| Sionna Therapeutics, Inc. (SION)vs › | $205.81M | 0.00% | 0.00% | 0.00% | 0.00% |
| Alector, Inc. (ALEC)vs › | $205.40M | -692.83% | -418.51% | -274.13% | -339.94% |
| Electra Therapeutics Inc. (ETRA)vs › | $208.65M | N/A | N/A | N/A | N/A |
| Entrada Therapeutics, Inc. (TRDA)vs › | $208.47M | -613.66% | -295.68% | -148.45% | -98.97% |
| Exagen Inc. (XGN)vs › | $200.49M | -18.58% | -22.82% | -47.54% | -46.03% |
| Compugen Ltd. (CGEN)vs › | $211.33M | 40.94% | -5.20% | -130.22% | -446.71% |
| Prelude Therapeutics Incorporated (PRLD)vs › | $211.79M | -861.33% | -1428.62% | -714.31% | -476.21% |
Gross Margin
100.0%
Operating Margin
-3099.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | -33973.08% |
| 2025-12-31 | -2316.68% |
| 2025-09-30 | -4660.62% |
| 2025-06-30 | -7319.13% |
| 2025-03-31 | -1989.91% |
| 2024-12-31 | 3521.87% |
| 2024-09-30 | -4541.34% |
| 2024-06-30 | 41.13% |
| 2024-03-31 | -228.56% |
| 2023-12-31 | -439.54% |
| 2023-09-30 | -199.44% |
| 2023-06-30 | -355.08% |
| 2023-03-31 | -309.55% |
| 2022-12-31 | -50.59% |
| 2022-09-30 | -7.72% |
| 2022-06-30 | 35.29% |
| 2022-03-31 | 31.69% |
| 2021-12-31 | 13.62% |
| 2021-09-30 | -8.06% |
| 2021-06-30 | 2.30% |
| 2021-03-31 | -64.78% |
| 2020-12-31 | -66.09% |
| 2020-09-30 | -295.61% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | -188.91% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | -124884.62% |
| 2019-03-31 | -118560.00% |
| 2018-12-31 | -1605.65% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | -113394.12% |
| 2017-09-30 | -51311.11% |
| 2017-06-30 | -61042.31% |
| 2017-03-31 | -10789.78% |
| 2016-12-31 | -473.04% |
| 2016-09-30 | -712.60% |
| 2016-06-30 | -317.35% |
| 2016-03-31 | -332.42% |
| 2015-12-31 | -333.04% |
| 2015-09-30 | -377.78% |
| 2015-06-30 | -511.00% |
| 2015-03-31 | -561.90% |
